Listen

Johnson & Johnson

Updated on Nov. 21 at 4 p.m. ET

A global megacorporation best known for Band-Aids and baby powder is now on the hook for about $107 million less than originally anticipated over its role in Oklahoma's opioid crisis.

In a judgment filed Friday, state District Judge Thad Balkman revised an earlier ruling against Johnson & Johnson and told the drugmaker to make a onetime payment of $465 million — not the $572 million he had originally ordered.

Updated at 5:37 p.m. ET

Confronted with a torrent of lawsuits across the U.S., several major drug companies are in discussions with authorities to resolve thousands of opioid-related suits filed against them. A government source close to the negotiations tells NPR that Purdue Pharma, Johnson & Johnson, Endo International and Allergan are looking to cut deals.

Updated at 7:04 p.m. ET

An Oklahoma judge has ruled that drugmaker Johnson & Johnson helped ignite the state's opioid crisis by deceptively marketing painkillers, and must pay $572 million to the state.

Oklahoma sought $17.5 billion, blaming Johnson & Johnson for fueling the crisis that has claimed the lives of more than 6,000 people in the state.

columbus.gov

The City of Columbus has filed a lawsuit against three drug manufacturers, five distributors and three individuals the city council president calls 'opinion leaders' for their alleged roles in the opioid crisis.

Ohio Public Radio

Republican Ohio Attorney General Mike DeWine has filed a lawsuit against five major drug companies, saying they have contributed to the opioid epidemic.

As Ohio's heroin overdose epidemic nears a record high in deaths, lobbyists representing prescription drug makers poured more than 3.5 million into Ohio political coffers over the last decade.

Dublin-based Cardinal Health will buy a Michigan-based pharmaceutical distributor called The Harvard Drug Group for 1.12 billion dollars.

Ohio Gets Share Of Settlement With Drug Maker

Nov 5, 2013

Ohio's Medicaid program will receive 52.7 million dollars from the newly-announced 2.2 billion dollar national settlement with Johnson & Johnson and a subsidiary.